Knee pain caused by osteoarthritis is suffered by millions of people worldwide1. GenVisc*850, a 5-injection hyaluronic acid, may help relieve OA-related knee pain in patients who are unresponsive to non-pharmacologic therapy and simple analgesics. GenVisc*850 is approved for 5 injections, but some patients may benefit from as few as 3 injections.
Unique Reimbursement Code J7320
Proven
- GenVisc*850 is approved in 64 countries with over 45 million syringes distributed worldwide2
- GenVisc*850 has the largest and longest duration double blind clinical study of hyaluronic acids for knee osteoarthritis.3
- GenVisc*850 has been published in over 30 clinical studies.4
Safe5
- Safe as saline placebo
- Free of avian proteins
- Demonstrated safe for repeat injection cycles
Effective
- Provides significant pain relief with results that last up to 6 months
-
Demonstrated improvement in pain relief up to 30 weeks post first injection cycle 7
- Demonstrated improvement of total WOMAC index at 30 weeks: Pain, stiffness and functional capacity8
GenVisc*850 Product Resources
Links to open new windows with PDF’s:
Full Prescribing and Safety Information
Billing and Coding Guide
Physician Product Brochure
45 Million doses administrated worldwide.9